591 related articles for article (PubMed ID: 19619623)
1. The canine kallikrein-related peptidase 14: structural characterization, alternative splicing and differential expression in mammary cancer.
Angelopoulou K; Prassas I; Yousef GM
Gene; 2009 Oct; 446(2):68-74. PubMed ID: 19619623
[TBL] [Abstract][Full Text] [Related]
2. Structural characterization and expression of five novel canine kallikrein-related peptidases in mammary cancer.
Angelopoulou K; Karagiannis GS
Mamm Genome; 2010 Oct; 21(9-10):516-24. PubMed ID: 20853168
[TBL] [Abstract][Full Text] [Related]
3. The canine kallikrein-related peptidases 9 and 10: structural characterization and expression in mammary cancer.
Angelopoulou K; Karagiannis GS
Mamm Genome; 2009; 20(11-12):758-67. PubMed ID: 19953256
[TBL] [Abstract][Full Text] [Related]
4. Identification, Molecular Characterization and Alternative Splicing of Three Novel Members of the Canine Kallikrein (Klk)-related Peptidase Family.
Angelopoulou K; Karagiannis GS
Anticancer Res; 2015 May; 35(5):2715-23. PubMed ID: 25964550
[TBL] [Abstract][Full Text] [Related]
5. Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies.
Yousef GM; Magklara A; Chang A; Jung K; Katsaros D; Diamandis EP
Cancer Res; 2001 Apr; 61(8):3425-31. PubMed ID: 11309303
[TBL] [Abstract][Full Text] [Related]
6. Identification and molecular characterization of five novel kallikrein gene 13 (KLK13; KLK-L4) splice variants: differential expression in the human testis and testicular cancer.
Chang A; Yousef GM; Jung K; Rajpert-De Meyts E; Diamandis EP
Anticancer Res; 2001; 21(5):3147-52. PubMed ID: 11848466
[TBL] [Abstract][Full Text] [Related]
7. Telomerase reverse transcriptase (TERT) expression in canine mammary tissues: a specific marker for malignancy?
Zavlaris M; Angelopoulou K; Vlemmas I; Papaioannou N
Anticancer Res; 2009 Jan; 29(1):319-25. PubMed ID: 19331168
[TBL] [Abstract][Full Text] [Related]
8. Canis familiaris telomerase reverse transcriptase undergoes alternative splicing.
Angelopoulou K; Zavlaris M; Papaioannou N; Vlemmas I
Mamm Genome; 2008 Sep; 19(9):647-53. PubMed ID: 18836773
[TBL] [Abstract][Full Text] [Related]
9. Lactation-dependent expression of an mRNA splice variant with an exon for a multiply O-glycosylated domain of mouse milk fat globule glycoprotein MFG-E8.
Oshima K; Aoki N; Negi M; Kishi M; Kitajima K; Matsuda T
Biochem Biophys Res Commun; 1999 Jan; 254(3):522-8. PubMed ID: 9920772
[TBL] [Abstract][Full Text] [Related]
10. Kallikrein-related peptidase (KLK) family mRNA variants and protein isoforms in hormone-related cancers: do they have a function?
Tan OL; Whitbread AK; Clements JA; Dong Y
Biol Chem; 2006 Jun; 387(6):697-705. PubMed ID: 16800730
[TBL] [Abstract][Full Text] [Related]
11. KLK12 is a novel serine protease and a new member of the human kallikrein gene family-differential expression in breast cancer.
Yousef GM; Magklara A; Diamandis EP
Genomics; 2000 Nov; 69(3):331-41. PubMed ID: 11056051
[TBL] [Abstract][Full Text] [Related]
12. Sequence, "subtle" alternative splicing and expression of the CYYR1 (cysteine/tyrosine-rich 1) mRNA in human neuroendocrine tumors.
Vitale L; Frabetti F; Huntsman SA; Canaider S; Casadei R; Lenzi L; Facchin F; Carinci P; Zannotti M; Coppola D; Strippoli P
BMC Cancer; 2007 Apr; 7():66. PubMed ID: 17442112
[TBL] [Abstract][Full Text] [Related]
13. The expanded human kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-L3 (KLK9).
Yousef GM; Diamandis EP
Genomics; 2000 Apr; 65(2):184-94. PubMed ID: 10783266
[TBL] [Abstract][Full Text] [Related]
14. Parallel overexpression of seven kallikrein genes in ovarian cancer.
Yousef GM; Polymeris ME; Yacoub GM; Scorilas A; Soosaipillai A; Popalis C; Fracchioli S; Katsaros D; Diamandis EP
Cancer Res; 2003 May; 63(9):2223-7. PubMed ID: 12727843
[TBL] [Abstract][Full Text] [Related]
15. Cloning and characterization of novel isoforms of the human kallikrein 6 gene.
Pampalakis G; Kurlender L; Diamandis EP; Sotiropoulou G
Biochem Biophys Res Commun; 2004 Jul; 320(1):54-61. PubMed ID: 15207701
[TBL] [Abstract][Full Text] [Related]
16. The expanded human kallikrein (KLK) gene family: genomic organisation, tissue-specific expression and potential functions.
Clements J; Hooper J; Dong Y; Harvey T
Biol Chem; 2001 Jan; 382(1):5-14. PubMed ID: 11258672
[TBL] [Abstract][Full Text] [Related]
17. cDNA microarray profiles of canine mammary tumour cell lines reveal deregulated pathways pertaining to their phenotype.
Rao NA; van Wolferen ME; van den Ham R; van Leenen D; Groot Koerkamp MJ; Holstege FC; Mol JA
Anim Genet; 2008 Aug; 39(4):333-45. PubMed ID: 18462483
[TBL] [Abstract][Full Text] [Related]
18. Identification of tumour-associated and germ line p53 mutations in canine mammary cancer.
Veldhoen N; Watterson J; Brash M; Milner J
Br J Cancer; 1999 Oct; 81(3):409-15. PubMed ID: 10507764
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of KLK14, a novel kallikrein serine protease gene located on human chromosome 19q13.4 and expressed in prostate and skeletal muscle.
Hooper JD; Bui LT; Rae FK; Harvey TJ; Myers SA; Ashworth LK; Clements JA
Genomics; 2001 Apr; 73(1):117-22. PubMed ID: 11352573
[TBL] [Abstract][Full Text] [Related]
20. Genomic architecture and transcriptional activation of the mouse and human tumor susceptibility gene TSG101: common types of shorter transcripts are true alternative splice variants.
Wagner KU; Dierisseau P; Rucker EB; Robinson GW; Hennighausen L
Oncogene; 1998 Nov; 17(21):2761-70. PubMed ID: 9840940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
